| Literature DB >> 27170091 |
Khemayanto Hidayat1, Guo-Chong Chen1, Ru Zhang1, Xuan Du2, Sheng-Yi Zou2, Bi-Min Shi2, Li-Qiang Qin1.
Abstract
Findings from observational studies have suggested a possible relation between Ca and breast cancer risk. However, the results of these studies are inconclusive, and the dose-response relationship between Ca intake and risk of breast cancer remains to be determined. A meta-analysis of prospective studies was conducted to address these issues. PubMed and Embase databases were searched for relevant studies concerning the association between Ca intake and breast cancer up to March 2016. The summary relative risks (RR) with 95 % CI were calculated with a random-effects model. The final analysis included eleven prospective cohort studies involving 26 606 cases and 872 895 participants. The overall RR of breast cancer for high v. low intake of Ca was 0·92 (95 % CI 0·85, 0·99), with moderate heterogeneity (P=0·026, I 2=44·2 %). In the subgroup analysis, the inverse association appeared stronger for premenopausal breast cancer (RR 0·75; 95 % CI 0·59, 0·96) than for postmenopausal breast cancer (RR 0·94; 95 % CI 0·87, 1·01). Dose-response analysis revealed that each 300 mg/d increase in Ca intake was associated with 2 % (RR 0·98; 95 % CI 0·96, 0·99), 8 % (RR 0·92; 95 % CI 0·87, 0·98) and 2 % (RR 0·98; 95 % CI 0·97, 0·99) reduction in the risk of total, premenopausal and postmenopausal breast cancer, respectively. Our findings suggest an inverse dose-response association between Ca intake and risk of breast cancer.Entities:
Keywords: Breast cancer; Calcium; Dose–response associations; ER oestrogen receptor; Meta-analyses; PR progesterone receptor; RR relative risk
Mesh：
Substances：
Year: 2016 PMID： 27170091 DOI： 10.1017/S0007114516001768
Source DB: PubMed Journal: Br J Nutr ISSN： 0007-1145 Impact factor: 3.718